Amino acids - PharmaKB

Amino acids

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

3749 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Depression	D003863	—	F33.9	49	85	34	48	44	240
Depressive disorder	D003866	EFO_1002014	F32.A	48	77	29	48	39	222
Healthy volunteers/patients	—	—	—	86	6	2	8	96	197
Postoperative pain	D010149	—	G89.18	19	24	34	78	54	192
Parkinson disease	D010300	EFO_0002508	G20	36	44	25	23	18	138
Major depressive disorder	D003865	EFO_0003761	F22	27	44	19	22	29	130
Pain	D010146	EFO_0003843	R52	10	14	23	49	36	126
Syndrome	D013577	—	—	13	37	18	19	24	103
Neoplasms	D009369	—	C80	27	28	17	1	13	79
Neuralgia	D009437	EFO_0009430	—	3	20	14	18	16	69

Show 432 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Leukemia	D007938	—	C95	22	51	21	—	1	85
Precursor cell lymphoblastic leukemia-lymphoma	D054198	—	C91.0	14	39	17	—	—	63
Lymphoma	D008223	—	C85.9	18	43	6	—	2	58
Lymphoid leukemia	D007945	—	C91	13	33	15	—	—	55
Myeloid leukemia acute	D015470	—	C92.0	16	27	3	—	1	41
Recurrence	D012008	—	—	18	29	1	—	2	41
Non-hodgkin lymphoma	D008228	—	C85.9	13	30	3	—	2	39
Multiple myeloma	D009101	—	C90.0	13	25	6	—	1	39
Myeloid leukemia	D007951	—	C92	16	27	2	—	—	39
Hypersensitivity	D006967	EFO_0003785	T78.40	1	2	1	—	33	37

Show 211 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Bcr-abl positive chronic myelogenous leukemia	D015464	EFO_0000340	—	6	20	—	—	—	22
Hodgkin disease	D006689	—	C81	6	16	—	—	—	19
Mantle-cell lymphoma	D020522	—	C83.1	4	16	—	—	—	17
Aging	D000375	GO_0007568	R41.81	1	1	—	—	15	17
B-cell chronic lymphocytic leukemia	D015451	—	C91.1	5	13	—	—	—	15
Myelomonocytic leukemia juvenile	D054429	—	C93.3	6	11	—	—	—	14
Metabolic syndrome	D024821	EFO_0000195	E88.810	—	1	—	—	13	14
Myelomonocytic leukemia chronic	D015477	—	C93.1	5	10	—	—	—	13
Weight loss	D015431	—	—	2	1	—	—	11	13
Primary myelofibrosis	D055728	—	D47.4	4	8	—	—	—	12

Show 238 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Hypertension	D006973	EFO_0000537	I10	3	—	—	—	9	12
Drug interactions	D004347	—	—	4	—	—	—	2	6
Pharmacokinetics	D010599	—	—	4	—	—	—	2	6
Pure autonomic failure	D054970	—	—	3	—	—	—	1	4
Brachial plexus block	D065527	—	—	1	—	—	—	3	4
Therapeutic equivalency	D013810	—	—	3	—	—	—	1	4
Inborn errors amino acid metabolism	D000592	—	—	1	—	—	—	3	4
End stage liver disease	D058625	EFO_1001311	K72.1	2	—	—	—	2	4
Mitochondrial diseases	D028361	EFO_0000591	—	1	—	—	—	2	3
Fistula	D005402	—	—	1	—	—	—	2	3

Show 97 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Metabolic diseases	D008659	EFO_0000589	E88.9	—	—	—	—	15	15
Exercise	D015444	EFO_0000483	—	—	—	—	—	10	10
Food hypersensitivity	D005512	EFO_1001890	—	—	—	—	—	10	10
Prediabetic state	D011236	EFO_1001121	R73.03	—	—	—	—	9	9
Malabsorption syndromes	D008286	EFO_0009554	K90	—	—	—	—	9	9
Kwashiorkor	D007732	EFO_1001009	E40	—	—	—	—	8	8
Pregnancy	D011247	EFO_0002950	Z33.1	—	—	—	—	7	7
Oxidative stress	D018384	EFO_1001905	—	—	—	—	—	6	6
Resistance training	D055070	—	—	—	—	—	—	6	6
Healthy diet	D000072001	—	—	—	—	—	—	4	4